Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ENROLLING BY INVITATION
NCT07168824
NA
An Open Label Trial Evaluating the Efficacy of Lacticaseibacillus Paracasei PS23 on Cognition
Sponsor: Chi-Chang Huang
View on ClinicalTrials.gov
Summary
This open label study aims to evaluate whether the consumption of probiotics can improve symptoms and overall quality of life in individuals experiencing cognitive decline symptoms, as well as to evaluate the effects of probiotics on blood-related biomarkers.
Key Details
Gender
All
Age Range
50 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2025-10-17
Completion Date
2026-12-31
Last Updated
2025-12-05
Healthy Volunteers
Yes
Conditions
Interventions
DIETARY_SUPPLEMENT
Lacticaseibacillus paracasei
one capsule daily for 12 weeks
Locations (1)
Graduate Institute of Sports Science, National Taiwan Sport University
Taoyuan District, Taiwan